Global Chimeric Antigen Receptor Cell Therapy Market Growth (Status and Outlook) 2025-2031
According to this study, the global Chimeric Antigen Receptor Cell Therapy market size will reach US$ million by 2031.
Chimeric Antigen Receptor (CAR) Cell Therapy is a type of immunotherapy that involves modifying a patient's own immune cells to recognize and attack cancer cells. The process begins by collecting the patient's T cells, a type of white blood cell, which are then genetically engineered to produce chimeric antigen receptors on their surface. These receptors enable the T cells to recognize specific proteins on the surface of cancer cells. Once the modified CAR T cells are infused back into the patient, they can target and destroy the cancer cells.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Chimeric Antigen Receptor Cell Therapy Industry Forecast” looks at past sales and reviews total world Chimeric Antigen Receptor Cell Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Chimeric Antigen Receptor Cell Therapy sales for 2025 through 2031. With Chimeric Antigen Receptor Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chimeric Antigen Receptor Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Chimeric Antigen Receptor Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Chimeric Antigen Receptor Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chimeric Antigen Receptor Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chimeric Antigen Receptor Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chimeric Antigen Receptor Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Chimeric Antigen Receptor Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Chimeric Antigen Receptor (CAR) Cell Therapy is a type of immunotherapy that involves modifying a patient's own immune cells to recognize and attack cancer cells. The process begins by collecting the patient's T cells, a type of white blood cell, which are then genetically engineered to produce chimeric antigen receptors on their surface. These receptors enable the T cells to recognize specific proteins on the surface of cancer cells. Once the modified CAR T cells are infused back into the patient, they can target and destroy the cancer cells.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Chimeric Antigen Receptor Cell Therapy Industry Forecast” looks at past sales and reviews total world Chimeric Antigen Receptor Cell Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Chimeric Antigen Receptor Cell Therapy sales for 2025 through 2031. With Chimeric Antigen Receptor Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chimeric Antigen Receptor Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Chimeric Antigen Receptor Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Chimeric Antigen Receptor Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chimeric Antigen Receptor Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chimeric Antigen Receptor Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chimeric Antigen Receptor Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Chimeric Antigen Receptor Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- MonOthersapy
- Combination Therapy
- Acute Leukemia
- Non-hodgkin's Lymphoma
- Multiple Myeloma
- Transplant Rejection
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen Inc
- Autolus Therapeutics Plc
- Beijing Immunochina Medical Science & Technology Co Ltd
- Bellicum Pharmaceuticals Inc
- Bristol-Myers Squibb Co
- bluebird bio Inc
- CARsgen Therapeutics Ltd
- Celgene Corp
- Cell Medica Ltd
- Cellular Biomedicine Group Inc
- Celularity Inc
- Celyad SA
- Daiichi Sankyo Co Ltd
- Fosun Pharmaceutical AG
- Gilead Sciences Inc
- Guangzhou Anjie Biomedical Technology Co Ltd
- Hangzhou Converd Co Ltd
- Hebei Senlang Biotechnology Inc Ltd
- HRAIN Biotechnology Co Ltd
- Juno Therapeutics Inc
- Kite Pharma Inc
- Nanjing Legend Biotech Co Ltd
- NantKwest Inc
- Nkarta Inc
- Novartis AG
- Ono Pharmaceutical Co Ltd
- Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
- Sorrento Therapeutics Inc
- Takara Bio Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chimeric Antigen Receptor Cell Therapy Market Size (2020-2031)
2.1.2 Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Chimeric Antigen Receptor Cell Therapy by Country/Region (2020, 2024 & 2031)
2.2 Chimeric Antigen Receptor Cell Therapy Segment by Type
2.2.1 MonOthersapy
2.2.2 Combination Therapy
2.3 Chimeric Antigen Receptor Cell Therapy Market Size by Type
2.3.1 Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2020-2025)
2.4 Chimeric Antigen Receptor Cell Therapy Segment by Application
2.4.1 Acute Leukemia
2.4.2 Non-hodgkin's Lymphoma
2.4.3 Multiple Myeloma
2.4.4 Transplant Rejection
2.4.5 Others
2.5 Chimeric Antigen Receptor Cell Therapy Market Size by Application
2.5.1 Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2020-2025)
3 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET SIZE BY PLAYER
3.1 Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Player
3.1.1 Global Chimeric Antigen Receptor Cell Therapy Revenue by Player (2020-2025)
3.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Chimeric Antigen Receptor Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY BY REGION
4.1 Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025)
4.2 Global Chimeric Antigen Receptor Cell Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Chimeric Antigen Receptor Cell Therapy Market Size Growth (2020-2025)
4.4 APAC Chimeric Antigen Receptor Cell Therapy Market Size Growth (2020-2025)
4.5 Europe Chimeric Antigen Receptor Cell Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025)
5.2 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025)
5.3 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025)
6.2 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025)
6.3 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025)
7.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025)
7.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy by Region (2020-2025)
8.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET FORECAST
10.1 Global Chimeric Antigen Receptor Cell Therapy Forecast by Region (2026-2031)
10.1.1 Global Chimeric Antigen Receptor Cell Therapy Forecast by Region (2026-2031)
10.1.2 Americas Chimeric Antigen Receptor Cell Therapy Forecast
10.1.3 APAC Chimeric Antigen Receptor Cell Therapy Forecast
10.1.4 Europe Chimeric Antigen Receptor Cell Therapy Forecast
10.1.5 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Forecast
10.2 Americas Chimeric Antigen Receptor Cell Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Chimeric Antigen Receptor Cell Therapy Forecast
10.2.2 Canada Market Chimeric Antigen Receptor Cell Therapy Forecast
10.2.3 Mexico Market Chimeric Antigen Receptor Cell Therapy Forecast
10.2.4 Brazil Market Chimeric Antigen Receptor Cell Therapy Forecast
10.3 APAC Chimeric Antigen Receptor Cell Therapy Forecast by Region (2026-2031)
10.3.1 China Chimeric Antigen Receptor Cell Therapy Market Forecast
10.3.2 Japan Market Chimeric Antigen Receptor Cell Therapy Forecast
10.3.3 Korea Market Chimeric Antigen Receptor Cell Therapy Forecast
10.3.4 Southeast Asia Market Chimeric Antigen Receptor Cell Therapy Forecast
10.3.5 India Market Chimeric Antigen Receptor Cell Therapy Forecast
10.3.6 Australia Market Chimeric Antigen Receptor Cell Therapy Forecast
10.4 Europe Chimeric Antigen Receptor Cell Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Chimeric Antigen Receptor Cell Therapy Forecast
10.4.2 France Market Chimeric Antigen Receptor Cell Therapy Forecast
10.4.3 UK Market Chimeric Antigen Receptor Cell Therapy Forecast
10.4.4 Italy Market Chimeric Antigen Receptor Cell Therapy Forecast
10.4.5 Russia Market Chimeric Antigen Receptor Cell Therapy Forecast
10.5 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Chimeric Antigen Receptor Cell Therapy Forecast
10.5.2 South Africa Market Chimeric Antigen Receptor Cell Therapy Forecast
10.5.3 Israel Market Chimeric Antigen Receptor Cell Therapy Forecast
10.5.4 Turkey Market Chimeric Antigen Receptor Cell Therapy Forecast
10.6 Global Chimeric Antigen Receptor Cell Therapy Forecast by Type (2026-2031)
10.7 Global Chimeric Antigen Receptor Cell Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Chimeric Antigen Receptor Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Amgen Inc
11.1.1 Amgen Inc Company Information
11.1.2 Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Amgen Inc Main Business Overview
11.1.5 Amgen Inc Latest Developments
11.2 Autolus Therapeutics Plc
11.2.1 Autolus Therapeutics Plc Company Information
11.2.2 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Offered
11.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Autolus Therapeutics Plc Main Business Overview
11.2.5 Autolus Therapeutics Plc Latest Developments
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Information
11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Main Business Overview
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Latest Developments
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Bellicum Pharmaceuticals Inc Company Information
11.4.2 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bellicum Pharmaceuticals Inc Main Business Overview
11.4.5 Bellicum Pharmaceuticals Inc Latest Developments
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Information
11.5.2 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Offered
11.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bristol-Myers Squibb Co Main Business Overview
11.5.5 Bristol-Myers Squibb Co Latest Developments
11.6 bluebird bio Inc
11.6.1 bluebird bio Inc Company Information
11.6.2 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 bluebird bio Inc Main Business Overview
11.6.5 bluebird bio Inc Latest Developments
11.7 CARsgen Therapeutics Ltd
11.7.1 CARsgen Therapeutics Ltd Company Information
11.7.2 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 CARsgen Therapeutics Ltd Main Business Overview
11.7.5 CARsgen Therapeutics Ltd Latest Developments
11.8 Celgene Corp
11.8.1 Celgene Corp Company Information
11.8.2 Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Offered
11.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Celgene Corp Main Business Overview
11.8.5 Celgene Corp Latest Developments
11.9 Cell Medica Ltd
11.9.1 Cell Medica Ltd Company Information
11.9.2 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Cell Medica Ltd Main Business Overview
11.9.5 Cell Medica Ltd Latest Developments
11.10 Cellular Biomedicine Group Inc
11.10.1 Cellular Biomedicine Group Inc Company Information
11.10.2 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Cellular Biomedicine Group Inc Main Business Overview
11.10.5 Cellular Biomedicine Group Inc Latest Developments
11.11 Celularity Inc
11.11.1 Celularity Inc Company Information
11.11.2 Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Celularity Inc Main Business Overview
11.11.5 Celularity Inc Latest Developments
11.12 Celyad SA
11.12.1 Celyad SA Company Information
11.12.2 Celyad SA Chimeric Antigen Receptor Cell Therapy Product Offered
11.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Celyad SA Main Business Overview
11.12.5 Celyad SA Latest Developments
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Company Information
11.13.2 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Daiichi Sankyo Co Ltd Main Business Overview
11.13.5 Daiichi Sankyo Co Ltd Latest Developments
11.14 Fosun Pharmaceutical AG
11.14.1 Fosun Pharmaceutical AG Company Information
11.14.2 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Offered
11.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Fosun Pharmaceutical AG Main Business Overview
11.14.5 Fosun Pharmaceutical AG Latest Developments
11.15 Gilead Sciences Inc
11.15.1 Gilead Sciences Inc Company Information
11.15.2 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Gilead Sciences Inc Main Business Overview
11.15.5 Gilead Sciences Inc Latest Developments
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Information
11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Main Business Overview
11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Latest Developments
11.17 Hangzhou Converd Co Ltd
11.17.1 Hangzhou Converd Co Ltd Company Information
11.17.2 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Hangzhou Converd Co Ltd Main Business Overview
11.17.5 Hangzhou Converd Co Ltd Latest Developments
11.18 Hebei Senlang Biotechnology Inc Ltd
11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Information
11.18.2 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Hebei Senlang Biotechnology Inc Ltd Main Business Overview
11.18.5 Hebei Senlang Biotechnology Inc Ltd Latest Developments
11.19 HRAIN Biotechnology Co Ltd
11.19.1 HRAIN Biotechnology Co Ltd Company Information
11.19.2 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 HRAIN Biotechnology Co Ltd Main Business Overview
11.19.5 HRAIN Biotechnology Co Ltd Latest Developments
11.20 Juno Therapeutics Inc
11.20.1 Juno Therapeutics Inc Company Information
11.20.2 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Juno Therapeutics Inc Main Business Overview
11.20.5 Juno Therapeutics Inc Latest Developments
11.21 Kite Pharma Inc
11.21.1 Kite Pharma Inc Company Information
11.21.2 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Kite Pharma Inc Main Business Overview
11.21.5 Kite Pharma Inc Latest Developments
11.22 Nanjing Legend Biotech Co Ltd
11.22.1 Nanjing Legend Biotech Co Ltd Company Information
11.22.2 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Nanjing Legend Biotech Co Ltd Main Business Overview
11.22.5 Nanjing Legend Biotech Co Ltd Latest Developments
11.23 NantKwest Inc
11.23.1 NantKwest Inc Company Information
11.23.2 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 NantKwest Inc Main Business Overview
11.23.5 NantKwest Inc Latest Developments
11.24 Nkarta Inc
11.24.1 Nkarta Inc Company Information
11.24.2 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 Nkarta Inc Main Business Overview
11.24.5 Nkarta Inc Latest Developments
11.25 Novartis AG
11.25.1 Novartis AG Company Information
11.25.2 Novartis AG Chimeric Antigen Receptor Cell Therapy Product Offered
11.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 Novartis AG Main Business Overview
11.25.5 Novartis AG Latest Developments
11.26 Ono Pharmaceutical Co Ltd
11.26.1 Ono Pharmaceutical Co Ltd Company Information
11.26.2 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.26.4 Ono Pharmaceutical Co Ltd Main Business Overview
11.26.5 Ono Pharmaceutical Co Ltd Latest Developments
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Information
11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Main Business Overview
11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Latest Developments
11.28 Sorrento Therapeutics Inc
11.28.1 Sorrento Therapeutics Inc Company Information
11.28.2 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.28.4 Sorrento Therapeutics Inc Main Business Overview
11.28.5 Sorrento Therapeutics Inc Latest Developments
11.29 Takara Bio Inc
11.29.1 Takara Bio Inc Company Information
11.29.2 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.29.4 Takara Bio Inc Main Business Overview
11.29.5 Takara Bio Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chimeric Antigen Receptor Cell Therapy Market Size (2020-2031)
2.1.2 Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Chimeric Antigen Receptor Cell Therapy by Country/Region (2020, 2024 & 2031)
2.2 Chimeric Antigen Receptor Cell Therapy Segment by Type
2.2.1 MonOthersapy
2.2.2 Combination Therapy
2.3 Chimeric Antigen Receptor Cell Therapy Market Size by Type
2.3.1 Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2020-2025)
2.4 Chimeric Antigen Receptor Cell Therapy Segment by Application
2.4.1 Acute Leukemia
2.4.2 Non-hodgkin's Lymphoma
2.4.3 Multiple Myeloma
2.4.4 Transplant Rejection
2.4.5 Others
2.5 Chimeric Antigen Receptor Cell Therapy Market Size by Application
2.5.1 Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2020-2025)
3 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET SIZE BY PLAYER
3.1 Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Player
3.1.1 Global Chimeric Antigen Receptor Cell Therapy Revenue by Player (2020-2025)
3.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Chimeric Antigen Receptor Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY BY REGION
4.1 Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025)
4.2 Global Chimeric Antigen Receptor Cell Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Chimeric Antigen Receptor Cell Therapy Market Size Growth (2020-2025)
4.4 APAC Chimeric Antigen Receptor Cell Therapy Market Size Growth (2020-2025)
4.5 Europe Chimeric Antigen Receptor Cell Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025)
5.2 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025)
5.3 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025)
6.2 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025)
6.3 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025)
7.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025)
7.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy by Region (2020-2025)
8.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET FORECAST
10.1 Global Chimeric Antigen Receptor Cell Therapy Forecast by Region (2026-2031)
10.1.1 Global Chimeric Antigen Receptor Cell Therapy Forecast by Region (2026-2031)
10.1.2 Americas Chimeric Antigen Receptor Cell Therapy Forecast
10.1.3 APAC Chimeric Antigen Receptor Cell Therapy Forecast
10.1.4 Europe Chimeric Antigen Receptor Cell Therapy Forecast
10.1.5 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Forecast
10.2 Americas Chimeric Antigen Receptor Cell Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Chimeric Antigen Receptor Cell Therapy Forecast
10.2.2 Canada Market Chimeric Antigen Receptor Cell Therapy Forecast
10.2.3 Mexico Market Chimeric Antigen Receptor Cell Therapy Forecast
10.2.4 Brazil Market Chimeric Antigen Receptor Cell Therapy Forecast
10.3 APAC Chimeric Antigen Receptor Cell Therapy Forecast by Region (2026-2031)
10.3.1 China Chimeric Antigen Receptor Cell Therapy Market Forecast
10.3.2 Japan Market Chimeric Antigen Receptor Cell Therapy Forecast
10.3.3 Korea Market Chimeric Antigen Receptor Cell Therapy Forecast
10.3.4 Southeast Asia Market Chimeric Antigen Receptor Cell Therapy Forecast
10.3.5 India Market Chimeric Antigen Receptor Cell Therapy Forecast
10.3.6 Australia Market Chimeric Antigen Receptor Cell Therapy Forecast
10.4 Europe Chimeric Antigen Receptor Cell Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Chimeric Antigen Receptor Cell Therapy Forecast
10.4.2 France Market Chimeric Antigen Receptor Cell Therapy Forecast
10.4.3 UK Market Chimeric Antigen Receptor Cell Therapy Forecast
10.4.4 Italy Market Chimeric Antigen Receptor Cell Therapy Forecast
10.4.5 Russia Market Chimeric Antigen Receptor Cell Therapy Forecast
10.5 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Chimeric Antigen Receptor Cell Therapy Forecast
10.5.2 South Africa Market Chimeric Antigen Receptor Cell Therapy Forecast
10.5.3 Israel Market Chimeric Antigen Receptor Cell Therapy Forecast
10.5.4 Turkey Market Chimeric Antigen Receptor Cell Therapy Forecast
10.6 Global Chimeric Antigen Receptor Cell Therapy Forecast by Type (2026-2031)
10.7 Global Chimeric Antigen Receptor Cell Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Chimeric Antigen Receptor Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Amgen Inc
11.1.1 Amgen Inc Company Information
11.1.2 Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Amgen Inc Main Business Overview
11.1.5 Amgen Inc Latest Developments
11.2 Autolus Therapeutics Plc
11.2.1 Autolus Therapeutics Plc Company Information
11.2.2 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Offered
11.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Autolus Therapeutics Plc Main Business Overview
11.2.5 Autolus Therapeutics Plc Latest Developments
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Information
11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Main Business Overview
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Latest Developments
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Bellicum Pharmaceuticals Inc Company Information
11.4.2 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bellicum Pharmaceuticals Inc Main Business Overview
11.4.5 Bellicum Pharmaceuticals Inc Latest Developments
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Information
11.5.2 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Offered
11.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bristol-Myers Squibb Co Main Business Overview
11.5.5 Bristol-Myers Squibb Co Latest Developments
11.6 bluebird bio Inc
11.6.1 bluebird bio Inc Company Information
11.6.2 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 bluebird bio Inc Main Business Overview
11.6.5 bluebird bio Inc Latest Developments
11.7 CARsgen Therapeutics Ltd
11.7.1 CARsgen Therapeutics Ltd Company Information
11.7.2 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 CARsgen Therapeutics Ltd Main Business Overview
11.7.5 CARsgen Therapeutics Ltd Latest Developments
11.8 Celgene Corp
11.8.1 Celgene Corp Company Information
11.8.2 Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Offered
11.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Celgene Corp Main Business Overview
11.8.5 Celgene Corp Latest Developments
11.9 Cell Medica Ltd
11.9.1 Cell Medica Ltd Company Information
11.9.2 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Cell Medica Ltd Main Business Overview
11.9.5 Cell Medica Ltd Latest Developments
11.10 Cellular Biomedicine Group Inc
11.10.1 Cellular Biomedicine Group Inc Company Information
11.10.2 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Cellular Biomedicine Group Inc Main Business Overview
11.10.5 Cellular Biomedicine Group Inc Latest Developments
11.11 Celularity Inc
11.11.1 Celularity Inc Company Information
11.11.2 Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Celularity Inc Main Business Overview
11.11.5 Celularity Inc Latest Developments
11.12 Celyad SA
11.12.1 Celyad SA Company Information
11.12.2 Celyad SA Chimeric Antigen Receptor Cell Therapy Product Offered
11.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Celyad SA Main Business Overview
11.12.5 Celyad SA Latest Developments
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Company Information
11.13.2 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Daiichi Sankyo Co Ltd Main Business Overview
11.13.5 Daiichi Sankyo Co Ltd Latest Developments
11.14 Fosun Pharmaceutical AG
11.14.1 Fosun Pharmaceutical AG Company Information
11.14.2 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Offered
11.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Fosun Pharmaceutical AG Main Business Overview
11.14.5 Fosun Pharmaceutical AG Latest Developments
11.15 Gilead Sciences Inc
11.15.1 Gilead Sciences Inc Company Information
11.15.2 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Gilead Sciences Inc Main Business Overview
11.15.5 Gilead Sciences Inc Latest Developments
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Information
11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Main Business Overview
11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Latest Developments
11.17 Hangzhou Converd Co Ltd
11.17.1 Hangzhou Converd Co Ltd Company Information
11.17.2 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Hangzhou Converd Co Ltd Main Business Overview
11.17.5 Hangzhou Converd Co Ltd Latest Developments
11.18 Hebei Senlang Biotechnology Inc Ltd
11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Information
11.18.2 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Hebei Senlang Biotechnology Inc Ltd Main Business Overview
11.18.5 Hebei Senlang Biotechnology Inc Ltd Latest Developments
11.19 HRAIN Biotechnology Co Ltd
11.19.1 HRAIN Biotechnology Co Ltd Company Information
11.19.2 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 HRAIN Biotechnology Co Ltd Main Business Overview
11.19.5 HRAIN Biotechnology Co Ltd Latest Developments
11.20 Juno Therapeutics Inc
11.20.1 Juno Therapeutics Inc Company Information
11.20.2 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Juno Therapeutics Inc Main Business Overview
11.20.5 Juno Therapeutics Inc Latest Developments
11.21 Kite Pharma Inc
11.21.1 Kite Pharma Inc Company Information
11.21.2 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Kite Pharma Inc Main Business Overview
11.21.5 Kite Pharma Inc Latest Developments
11.22 Nanjing Legend Biotech Co Ltd
11.22.1 Nanjing Legend Biotech Co Ltd Company Information
11.22.2 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Nanjing Legend Biotech Co Ltd Main Business Overview
11.22.5 Nanjing Legend Biotech Co Ltd Latest Developments
11.23 NantKwest Inc
11.23.1 NantKwest Inc Company Information
11.23.2 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 NantKwest Inc Main Business Overview
11.23.5 NantKwest Inc Latest Developments
11.24 Nkarta Inc
11.24.1 Nkarta Inc Company Information
11.24.2 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 Nkarta Inc Main Business Overview
11.24.5 Nkarta Inc Latest Developments
11.25 Novartis AG
11.25.1 Novartis AG Company Information
11.25.2 Novartis AG Chimeric Antigen Receptor Cell Therapy Product Offered
11.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 Novartis AG Main Business Overview
11.25.5 Novartis AG Latest Developments
11.26 Ono Pharmaceutical Co Ltd
11.26.1 Ono Pharmaceutical Co Ltd Company Information
11.26.2 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.26.4 Ono Pharmaceutical Co Ltd Main Business Overview
11.26.5 Ono Pharmaceutical Co Ltd Latest Developments
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Information
11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Main Business Overview
11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Latest Developments
11.28 Sorrento Therapeutics Inc
11.28.1 Sorrento Therapeutics Inc Company Information
11.28.2 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.28.4 Sorrento Therapeutics Inc Main Business Overview
11.28.5 Sorrento Therapeutics Inc Latest Developments
11.29 Takara Bio Inc
11.29.1 Takara Bio Inc Company Information
11.29.2 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.29.4 Takara Bio Inc Main Business Overview
11.29.5 Takara Bio Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Chimeric Antigen Receptor Cell Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of MonOthersapy
Table 4. Major Players of Combination Therapy
Table 5. Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2020-2025)
Table 8. Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2020-2025)
Table 11. Global Chimeric Antigen Receptor Cell Therapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Player (2020-2025)
Table 13. Chimeric Antigen Receptor Cell Therapy Key Players Head office and Products Offered
Table 14. Chimeric Antigen Receptor Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region (2020-2025)
Table 19. Global Chimeric Antigen Receptor Cell Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Country (2020-2025)
Table 23. Americas Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2020-2025)
Table 25. Americas Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2020-2025)
Table 27. APAC Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region (2020-2025)
Table 29. APAC Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Country (2020-2025)
Table 33. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Chimeric Antigen Receptor Cell Therapy
Table 39. Key Market Challenges & Risks of Chimeric Antigen Receptor Cell Therapy
Table 40. Key Industry Trends of Chimeric Antigen Receptor Cell Therapy
Table 41. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Amgen Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 46. Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 47. Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Amgen Inc Main Business
Table 49. Amgen Inc Latest Developments
Table 50. Autolus Therapeutics Plc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 51. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 52. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Autolus Therapeutics Plc Main Business
Table 54. Autolus Therapeutics Plc Latest Developments
Table 55. Beijing Immunochina Medical Science & Technology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 56. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 57. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Beijing Immunochina Medical Science & Technology Co Ltd Main Business
Table 59. Beijing Immunochina Medical Science & Technology Co Ltd Latest Developments
Table 60. Bellicum Pharmaceuticals Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 61. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 62. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Bellicum Pharmaceuticals Inc Main Business
Table 64. Bellicum Pharmaceuticals Inc Latest Developments
Table 65. Bristol-Myers Squibb Co Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 66. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Offered
Table 67. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Bristol-Myers Squibb Co Main Business
Table 69. Bristol-Myers Squibb Co Latest Developments
Table 70. bluebird bio Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 71. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 72. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. bluebird bio Inc Main Business
Table 74. bluebird bio Inc Latest Developments
Table 75. CARsgen Therapeutics Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 76. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 77. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. CARsgen Therapeutics Ltd Main Business
Table 79. CARsgen Therapeutics Ltd Latest Developments
Table 80. Celgene Corp Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 81. Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Offered
Table 82. Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Celgene Corp Main Business
Table 84. Celgene Corp Latest Developments
Table 85. Cell Medica Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 86. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 87. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Cell Medica Ltd Main Business
Table 89. Cell Medica Ltd Latest Developments
Table 90. Cellular Biomedicine Group Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 91. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 92. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Cellular Biomedicine Group Inc Main Business
Table 94. Cellular Biomedicine Group Inc Latest Developments
Table 95. Celularity Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 96. Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 97. Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Celularity Inc Main Business
Table 99. Celularity Inc Latest Developments
Table 100. Celyad SA Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 101. Celyad SA Chimeric Antigen Receptor Cell Therapy Product Offered
Table 102. Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Celyad SA Main Business
Table 104. Celyad SA Latest Developments
Table 105. Daiichi Sankyo Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 106. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 107. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Daiichi Sankyo Co Ltd Main Business
Table 109. Daiichi Sankyo Co Ltd Latest Developments
Table 110. Fosun Pharmaceutical AG Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 111. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Offered
Table 112. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Fosun Pharmaceutical AG Main Business
Table 114. Fosun Pharmaceutical AG Latest Developments
Table 115. Gilead Sciences Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 116. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 117. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Gilead Sciences Inc Main Business
Table 119. Gilead Sciences Inc Latest Developments
Table 120. Guangzhou Anjie Biomedical Technology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 121. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 122. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Guangzhou Anjie Biomedical Technology Co Ltd Main Business
Table 124. Guangzhou Anjie Biomedical Technology Co Ltd Latest Developments
Table 125. Hangzhou Converd Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 126. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 127. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Hangzhou Converd Co Ltd Main Business
Table 129. Hangzhou Converd Co Ltd Latest Developments
Table 130. Hebei Senlang Biotechnology Inc Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 131. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 132. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Hebei Senlang Biotechnology Inc Ltd Main Business
Table 134. Hebei Senlang Biotechnology Inc Ltd Latest Developments
Table 135. HRAIN Biotechnology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 136. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 137. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. HRAIN Biotechnology Co Ltd Main Business
Table 139. HRAIN Biotechnology Co Ltd Latest Developments
Table 140. Juno Therapeutics Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 141. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 142. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Juno Therapeutics Inc Main Business
Table 144. Juno Therapeutics Inc Latest Developments
Table 145. Kite Pharma Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 146. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 147. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Kite Pharma Inc Main Business
Table 149. Kite Pharma Inc Latest Developments
Table 150. Nanjing Legend Biotech Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 151. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 152. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 153. Nanjing Legend Biotech Co Ltd Main Business
Table 154. Nanjing Legend Biotech Co Ltd Latest Developments
Table 155. NantKwest Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 156. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 157. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 158. NantKwest Inc Main Business
Table 159. NantKwest Inc Latest Developments
Table 160. Nkarta Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 161. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 162. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 163. Nkarta Inc Main Business
Table 164. Nkarta Inc Latest Developments
Table 165. Novartis AG Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 166. Novartis AG Chimeric Antigen Receptor Cell Therapy Product Offered
Table 167. Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 168. Novartis AG Main Business
Table 169. Novartis AG Latest Developments
Table 170. Ono Pharmaceutical Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 171. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 172. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 173. Ono Pharmaceutical Co Ltd Main Business
Table 174. Ono Pharmaceutical Co Ltd Latest Developments
Table 175. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 176. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 177. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 178. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Main Business
Table 179. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Latest Developments
Table 180. Sorrento Therapeutics Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 181. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 182. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 183. Sorrento Therapeutics Inc Main Business
Table 184. Sorrento Therapeutics Inc Latest Developments
Table 185. Takara Bio Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 186. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 187. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 188. Takara Bio Inc Main Business
Table 189. Takara Bio Inc Latest Developments
Table 1. Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Chimeric Antigen Receptor Cell Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of MonOthersapy
Table 4. Major Players of Combination Therapy
Table 5. Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2020-2025)
Table 8. Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2020-2025)
Table 11. Global Chimeric Antigen Receptor Cell Therapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Player (2020-2025)
Table 13. Chimeric Antigen Receptor Cell Therapy Key Players Head office and Products Offered
Table 14. Chimeric Antigen Receptor Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region (2020-2025)
Table 19. Global Chimeric Antigen Receptor Cell Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Country (2020-2025)
Table 23. Americas Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2020-2025)
Table 25. Americas Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2020-2025)
Table 27. APAC Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region (2020-2025)
Table 29. APAC Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Country (2020-2025)
Table 33. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Chimeric Antigen Receptor Cell Therapy
Table 39. Key Market Challenges & Risks of Chimeric Antigen Receptor Cell Therapy
Table 40. Key Industry Trends of Chimeric Antigen Receptor Cell Therapy
Table 41. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Amgen Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 46. Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 47. Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Amgen Inc Main Business
Table 49. Amgen Inc Latest Developments
Table 50. Autolus Therapeutics Plc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 51. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 52. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Autolus Therapeutics Plc Main Business
Table 54. Autolus Therapeutics Plc Latest Developments
Table 55. Beijing Immunochina Medical Science & Technology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 56. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 57. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Beijing Immunochina Medical Science & Technology Co Ltd Main Business
Table 59. Beijing Immunochina Medical Science & Technology Co Ltd Latest Developments
Table 60. Bellicum Pharmaceuticals Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 61. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 62. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Bellicum Pharmaceuticals Inc Main Business
Table 64. Bellicum Pharmaceuticals Inc Latest Developments
Table 65. Bristol-Myers Squibb Co Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 66. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Offered
Table 67. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Bristol-Myers Squibb Co Main Business
Table 69. Bristol-Myers Squibb Co Latest Developments
Table 70. bluebird bio Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 71. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 72. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. bluebird bio Inc Main Business
Table 74. bluebird bio Inc Latest Developments
Table 75. CARsgen Therapeutics Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 76. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 77. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. CARsgen Therapeutics Ltd Main Business
Table 79. CARsgen Therapeutics Ltd Latest Developments
Table 80. Celgene Corp Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 81. Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Offered
Table 82. Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Celgene Corp Main Business
Table 84. Celgene Corp Latest Developments
Table 85. Cell Medica Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 86. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 87. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Cell Medica Ltd Main Business
Table 89. Cell Medica Ltd Latest Developments
Table 90. Cellular Biomedicine Group Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 91. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 92. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Cellular Biomedicine Group Inc Main Business
Table 94. Cellular Biomedicine Group Inc Latest Developments
Table 95. Celularity Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 96. Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 97. Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Celularity Inc Main Business
Table 99. Celularity Inc Latest Developments
Table 100. Celyad SA Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 101. Celyad SA Chimeric Antigen Receptor Cell Therapy Product Offered
Table 102. Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Celyad SA Main Business
Table 104. Celyad SA Latest Developments
Table 105. Daiichi Sankyo Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 106. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 107. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Daiichi Sankyo Co Ltd Main Business
Table 109. Daiichi Sankyo Co Ltd Latest Developments
Table 110. Fosun Pharmaceutical AG Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 111. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Offered
Table 112. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Fosun Pharmaceutical AG Main Business
Table 114. Fosun Pharmaceutical AG Latest Developments
Table 115. Gilead Sciences Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 116. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 117. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Gilead Sciences Inc Main Business
Table 119. Gilead Sciences Inc Latest Developments
Table 120. Guangzhou Anjie Biomedical Technology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 121. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 122. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Guangzhou Anjie Biomedical Technology Co Ltd Main Business
Table 124. Guangzhou Anjie Biomedical Technology Co Ltd Latest Developments
Table 125. Hangzhou Converd Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 126. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 127. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Hangzhou Converd Co Ltd Main Business
Table 129. Hangzhou Converd Co Ltd Latest Developments
Table 130. Hebei Senlang Biotechnology Inc Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 131. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 132. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Hebei Senlang Biotechnology Inc Ltd Main Business
Table 134. Hebei Senlang Biotechnology Inc Ltd Latest Developments
Table 135. HRAIN Biotechnology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 136. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 137. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. HRAIN Biotechnology Co Ltd Main Business
Table 139. HRAIN Biotechnology Co Ltd Latest Developments
Table 140. Juno Therapeutics Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 141. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 142. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Juno Therapeutics Inc Main Business
Table 144. Juno Therapeutics Inc Latest Developments
Table 145. Kite Pharma Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 146. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 147. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Kite Pharma Inc Main Business
Table 149. Kite Pharma Inc Latest Developments
Table 150. Nanjing Legend Biotech Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 151. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 152. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 153. Nanjing Legend Biotech Co Ltd Main Business
Table 154. Nanjing Legend Biotech Co Ltd Latest Developments
Table 155. NantKwest Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 156. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 157. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 158. NantKwest Inc Main Business
Table 159. NantKwest Inc Latest Developments
Table 160. Nkarta Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 161. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 162. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 163. Nkarta Inc Main Business
Table 164. Nkarta Inc Latest Developments
Table 165. Novartis AG Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 166. Novartis AG Chimeric Antigen Receptor Cell Therapy Product Offered
Table 167. Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 168. Novartis AG Main Business
Table 169. Novartis AG Latest Developments
Table 170. Ono Pharmaceutical Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 171. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 172. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 173. Ono Pharmaceutical Co Ltd Main Business
Table 174. Ono Pharmaceutical Co Ltd Latest Developments
Table 175. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 176. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 177. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 178. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Main Business
Table 179. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Latest Developments
Table 180. Sorrento Therapeutics Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 181. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 182. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 183. Sorrento Therapeutics Inc Main Business
Table 184. Sorrento Therapeutics Inc Latest Developments
Table 185. Takara Bio Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 186. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 187. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 188. Takara Bio Inc Main Business
Table 189. Takara Bio Inc Latest Developments
LIST OF FIGURES
Figure 1. Chimeric Antigen Receptor Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Chimeric Antigen Receptor Cell Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Chimeric Antigen Receptor Cell Therapy Sales Market Share by Country/Region (2024)
Figure 8. Chimeric Antigen Receptor Cell Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type in 2024
Figure 10. Chimeric Antigen Receptor Cell Therapy in Acute Leukemia
Figure 11. Global Chimeric Antigen Receptor Cell Therapy Market: Acute Leukemia (2020-2025) & ($ millions)
Figure 12. Chimeric Antigen Receptor Cell Therapy in Non-hodgkin's Lymphoma
Figure 13. Global Chimeric Antigen Receptor Cell Therapy Market: Non-hodgkin's Lymphoma (2020-2025) & ($ millions)
Figure 14. Chimeric Antigen Receptor Cell Therapy in Multiple Myeloma
Figure 15. Global Chimeric Antigen Receptor Cell Therapy Market: Multiple Myeloma (2020-2025) & ($ millions)
Figure 16. Chimeric Antigen Receptor Cell Therapy in Transplant Rejection
Figure 17. Global Chimeric Antigen Receptor Cell Therapy Market: Transplant Rejection (2020-2025) & ($ millions)
Figure 18. Chimeric Antigen Receptor Cell Therapy in Others
Figure 19. Global Chimeric Antigen Receptor Cell Therapy Market: Others (2020-2025) & ($ millions)
Figure 20. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application in 2024
Figure 21. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Player in 2024
Figure 22. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region (2020-2025)
Figure 23. Americas Chimeric Antigen Receptor Cell Therapy Market Size 2020-2025 ($ millions)
Figure 24. APAC Chimeric Antigen Receptor Cell Therapy Market Size 2020-2025 ($ millions)
Figure 25. Europe Chimeric Antigen Receptor Cell Therapy Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size 2020-2025 ($ millions)
Figure 27. Americas Chimeric Antigen Receptor Cell Therapy Value Market Share by Country in 2024
Figure 28. United States Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region in 2024
Figure 33. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2020-2025)
Figure 34. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2020-2025)
Figure 35. China Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. India Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Country in 2024
Figure 42. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2020-2025)
Figure 43. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2020-2025)
Figure 44. Germany Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. France Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 58. APAC Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 59. Europe Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 61. United States Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 62. Canada Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 63. Mexico Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 64. Brazil Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 65. China Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 66. Japan Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 67. Korea Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 69. India Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 70. Australia Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 71. Germany Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 72. France Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 73. UK Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 74. Italy Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 75. Russia Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 76. Egypt Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 77. South Africa Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 78. Israel Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 79. Turkey Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 80. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 1. Chimeric Antigen Receptor Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Chimeric Antigen Receptor Cell Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Chimeric Antigen Receptor Cell Therapy Sales Market Share by Country/Region (2024)
Figure 8. Chimeric Antigen Receptor Cell Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type in 2024
Figure 10. Chimeric Antigen Receptor Cell Therapy in Acute Leukemia
Figure 11. Global Chimeric Antigen Receptor Cell Therapy Market: Acute Leukemia (2020-2025) & ($ millions)
Figure 12. Chimeric Antigen Receptor Cell Therapy in Non-hodgkin's Lymphoma
Figure 13. Global Chimeric Antigen Receptor Cell Therapy Market: Non-hodgkin's Lymphoma (2020-2025) & ($ millions)
Figure 14. Chimeric Antigen Receptor Cell Therapy in Multiple Myeloma
Figure 15. Global Chimeric Antigen Receptor Cell Therapy Market: Multiple Myeloma (2020-2025) & ($ millions)
Figure 16. Chimeric Antigen Receptor Cell Therapy in Transplant Rejection
Figure 17. Global Chimeric Antigen Receptor Cell Therapy Market: Transplant Rejection (2020-2025) & ($ millions)
Figure 18. Chimeric Antigen Receptor Cell Therapy in Others
Figure 19. Global Chimeric Antigen Receptor Cell Therapy Market: Others (2020-2025) & ($ millions)
Figure 20. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application in 2024
Figure 21. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Player in 2024
Figure 22. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region (2020-2025)
Figure 23. Americas Chimeric Antigen Receptor Cell Therapy Market Size 2020-2025 ($ millions)
Figure 24. APAC Chimeric Antigen Receptor Cell Therapy Market Size 2020-2025 ($ millions)
Figure 25. Europe Chimeric Antigen Receptor Cell Therapy Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size 2020-2025 ($ millions)
Figure 27. Americas Chimeric Antigen Receptor Cell Therapy Value Market Share by Country in 2024
Figure 28. United States Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region in 2024
Figure 33. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2020-2025)
Figure 34. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2020-2025)
Figure 35. China Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. India Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Country in 2024
Figure 42. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2020-2025)
Figure 43. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2020-2025)
Figure 44. Germany Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. France Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Chimeric Antigen Receptor Cell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 58. APAC Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 59. Europe Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 61. United States Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 62. Canada Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 63. Mexico Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 64. Brazil Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 65. China Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 66. Japan Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 67. Korea Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 69. India Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 70. Australia Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 71. Germany Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 72. France Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 73. UK Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 74. Italy Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 75. Russia Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 76. Egypt Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 77. South Africa Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 78. Israel Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 79. Turkey Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
Figure 80. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Chimeric Antigen Receptor Cell Therapy Market Size 2026-2031 ($ millions)
More Publications
Global Allergy Diagnostics And Treatment Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
114 pages
Global Human Parainfluenza Viruses Diagnostics Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
84 pages
Global Farm Animal Internal Parasiticide Market Growth 2025-2031
US$ 3,660.00
December 2025
104 pages
Global Adiponectin Testing Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
89 pages
